Frees sites from duplicate data entry and connects EHR and EDC for higher quality trial data, faster<\/i><\/p>\n
\nPLEASANTON, CA \u2014 Jan. 29, 2026 \u2014<\/strong> ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced ³Ô¹Ï±¬ÁÏ eSource<\/a>, a new ³Ô¹Ï±¬ÁÏ SiteVault<\/a> application designed to significantly reduce manual clinical trial processes and increase data quality. ³Ô¹Ï±¬ÁÏ eSource will eliminate paper at the site through a direct data capture application and streamline data through EDC integration, and EHR to EDC transfer.\n<\/p>\n \n“I\u2019m excited to see ³Ô¹Ï±¬ÁÏ eSource in action; although there are other options in use by sites, traditional eSource is still incredibly time-consuming to program, complete, and transfer data from eSource to EDC,\u201d said Alisha Garibaldi, CEO, Skylight Health Research. \u201cA seamless flow of data from ³Ô¹Ï±¬ÁÏ eSource to EDC will reduce errors, minimize QC processing, and allow us to spend more time where it matters \u2013 with our patients.”\n<\/p>\n \nWith ³Ô¹Ï±¬ÁÏ eSource, clinical trial data flows from site to sponsor with less effort through:<\/p>\n \n\u201cFor the first time, we are connecting data and processes to enable straight-through clinical data flow from site to sponsor,\u201d said Jim Reilly, president of ³Ô¹Ï±¬ÁÏ Development Cloud. \u201cIt is a major step toward our vision to simplify, standardize, and connect clinical trials for higher efficiency and a better experience for sponsors, sites, and patients.\u201d\n<\/p>\n \n\u201c³Ô¹Ï±¬ÁÏ eSource advances our goal of delivering significant efficiency and simplicity for clinical trial sites,\u201d said Nick Frenzer, general manager of ³Ô¹Ï±¬ÁÏ site solutions. \u201cBy delivering eSource, we can complete the picture to provide integrated data transparency across a site to improve trials.\u201d\n<\/p>\n \n³Ô¹Ï±¬ÁÏ eSource<\/a> is part of the ³Ô¹Ï±¬ÁÏ SiteVault platform and requires SiteVault CTMS at the site to simplify and streamline the visit experience for the site and patient. ³Ô¹Ï±¬ÁÏ eSource is planned for early adopter availability in the second half of 2026.\n<\/p>\n About ³Ô¹Ï±¬ÁÏ Systems<\/strong> ³Ô¹Ï±¬ÁÏ Forward-Looking Statements<\/strong> \nContact:<\/strong>\n<\/p>\n \nJeremy Whittaker\n
\n³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.\n<\/p>\n
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.\n<\/p>\n
\n³Ô¹Ï±¬ÁÏ Systems
\n+49-695-095-5486
\njeremy.whittaker@veeva.com<\/a>\n<\/p>\n